Table 1.
Genotype distribution of rs1655900 in susceptibility and severity cohorts.
| RS1655900 G>A | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| GG | % | GA | % | AA | % | Tot. | |||
| Susceptibility | CT− | 139 | 69.2% | 54 | 26.9% | 8 | 4.0% | 201 | |
| CT+ | 91 | 71.1% | 33 | 25.8% | 4 | 3.1% | 128 | ||
| AS | 51 | 70.8% | 17 | 23.6% | 4 | 5.6% | 72 | ||
| S | 28 | 70.0% | 12 | 30.0% | 0 | 0.0% | 40 | ||
| LAP | 12 | 75.0% | 4 | 25.0% | 0 | 0.0% | 16 | ||
| Severity | CT− | 278 | 67.3% | 113 | 27.3% | 22 | 5.3% | 413 | |
| CT− HSG− | 251 | 66.0% | 105 | 28.0% | 22 | 5.8% | 378 | ||
| CT+ | 42 | 72.4% | 14 | 24.1% | 2 | 3.4% | 58 | ||
| CT+ TP+ s.s. | 5 | 83.3% | 0 | 0.0% | 1 | 16.7% | 6 | ||
| CT+ TP+ d.s. | 5 | 100.0% | 0 | 0.0% | 0 | 0.0% | 5 | ||
| TP- | 21 | 61.8% | 13 | 38.2% | 0 | 0.0% | 34 | ||
CT: C. trachomatis; AS: asymptomatic; S: symptomatic; LAP: lower abdominal pain; TP: tubal pathology; s.s.: single-sided occlusion; d.s.: double-sided occlusion; +: positive; –: negative.